A new study backs up previous research regarding the effectiveness of ketamine in treating depression. Additionally, researchers identified antidepressant effects in Botox, Diclofenac and Minocycline, drugs commonly used for other purposes.
According to researchers, Botulinum toxin, or Botox, injections can help to reduce the frequency of chronic migraines. Compared to those treated with a placebo, migraine suffers experienced 1.6 fewer attacks per month following Botox injections.
Many people who suffer migraines are often diagnosed with other conditions. For those with a clinical diagnosis, many are unaware of treatment options available for pain and to slow the frequency of attacks.
Botox injections appear to improve symptoms of depression, regardless of the injection site, a new study reports. Researchers found depression was reported 40 - 88% less often in patients treated with Botox.